Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “breast adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02685631
What this trial is testing

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

Who this might be right for
Localized Non-Resectable Adult Liver Carcinoma
Vanderbilt-Ingram Cancer Center 1,653
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Not applicableStudy completedNCT02248662
What this trial is testing

Impact of Radiation Therapy on Breast Conservation in DCIS

Who this might be right for
DCIS
Dana-Farber Cancer Institute 3,436
Early research (Phase 1)Looking for participantsNCT06623396
What this trial is testing

Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Who this might be right for
Mesothelin PositiveMesothelin-Expressing TumorsEsophageal Adenocarcinoma+5 more
Memorial Sloan Kettering Cancer Center 18
Very early researchWithdrawnNCT02610920
What this trial is testing

Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection

Who this might be right for
Breast NeoplasmCarcinoma, Ductal, BreastCarcinoma, Intraductal, Noninfiltrating
Columbia University
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Not applicableStudy completedNCT00321048
What this trial is testing

Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC

Who this might be right for
Breast NeoplasmsCarcinoma, DuctalAdenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 57
Testing effectiveness (Phase 2)Ended earlyNCT03435640
What this trial is testing

REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies

Who this might be right for
MelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more
Nektar Therapeutics 64
Early research (Phase 1)Study completedNCT01588678
What this trial is testing

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorLymphoma
Daiichi Sankyo 32
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Early research (Phase 1)Study completedNCT03219268
What this trial is testing

MGD013 in Patients With Unresectable or Metastatic Neoplasms

Who this might be right for
Advanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more
MacroGenics 277
Not applicableStudy completedNCT00605982
What this trial is testing

Breast MRI as a Preoperative Tool for DCIS

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Memorial Sloan Kettering Cancer Center 115
Not applicableStudy completedNCT00665782
What this trial is testing

Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast

Who this might be right for
Anxiety DisorderBreast CancerDepression+1 more
Wake Forest University Health Sciences 24
Large-scale testing (Phase 3)Active Not RecruitingNCT01953588
What this trial is testing

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerInvasive Ductal Breast Carcinoma+6 more
Alliance for Clinical Trials in Oncology 1,473
Early research (Phase 1)Study completedNCT00003761
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT02067741
What this trial is testing

CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer

Who this might be right for
Metastatic Breast AdenocarcinomaBreast Cancer
Swiss Cancer Institute 29
Testing effectiveness (Phase 2)Study completedNCT00591851
What this trial is testing

Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 70
Not applicableStudy completedNCT01624220
What this trial is testing

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Who this might be right for
Spinal Tumor
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Looking for participantsNCT06265025
What this trial is testing

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerMalignant MelanomaColorectal Cancer+3 more
GeneMedicine Co., Ltd. 125
Not applicableLooking for participantsNCT07389408
What this trial is testing

A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

Who this might be right for
Breast CancerBreast Adenocarcinoma
National and Kapodistrian University of Athens 2,000
Next Page